Enhanced antiviral activity of acyclovir loaded into nanoparticles. 2012

Roberta Cavalli, and Manuela Donalisio, and Agnese Bisazza, and Andrea Civra, and Elisabetta Ranucci, and Paolo Ferruti, and David Lembo
Dipartimento di Scienza e Tecnologia del Farmaco, Università di Torino, Torino, Italy.

The activity of antivirals can be enhanced by their incorporation in nanoparticulate delivery systems. Peculiar polymeric nanoparticles, based on a β-cyclodextrin-poly(4-acryloylmorpholine) monoconjugate (β-CD-PACM), are proposed as acyclovir carriers. The experimental procedure necessary to obtain the acyclovir-loaded nanoparticles using the solvent displacement preparation method will be described in this chapter. Fluorescent labeled nanoparticles are prepared using the same method for cellular trafficking studies. The biocompatibility assays necessary to obtain safe nanoparticles are reported. Section 4 of this chapter describes the assessment of the antiviral activity of the acyclovir-loaded nanoparticles.

UI MeSH Term Description Entries
D008422 Materials Testing The testing of materials and devices, especially those used for PROSTHESES AND IMPLANTS; SUTURES; TISSUE ADHESIVES; etc., for hardness, strength, durability, safety, efficacy, and biocompatibility. Biocompatibility Testing,Biocompatible Materials Testing,Hemocompatibility Testing,Testing, Biocompatible Materials,Testing, Hemocompatible Materials,Hemocompatibility Testings,Hemocompatible Materials Testing,Materials Testing, Biocompatible,Materials Testing, Hemocompatible,Testing, Biocompatibility,Testing, Hemocompatibility,Testing, Materials,Testings, Biocompatibility
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D010948 Viral Plaque Assay Method for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE. Bacteriophage Plaque Assay,Assay, Bacteriophage Plaque,Assay, Viral Plaque,Assays, Bacteriophage Plaque,Assays, Viral Plaque,Bacteriophage Plaque Assays,Plaque Assay, Bacteriophage,Plaque Assay, Viral,Plaque Assays, Bacteriophage,Plaque Assays, Viral,Viral Plaque Assays
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000180 Acrylic Resins Polymers of high molecular weight which are derived from acrylic acid, methacrylic acid or other related compounds and are capable of being molded and then hardened to form useful components. Acrylic Resin,Resin, Acrylic,Resins, Acrylic
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U

Related Publications

Roberta Cavalli, and Manuela Donalisio, and Agnese Bisazza, and Andrea Civra, and Elisabetta Ranucci, and Paolo Ferruti, and David Lembo
February 2018, ACS omega,
Roberta Cavalli, and Manuela Donalisio, and Agnese Bisazza, and Andrea Civra, and Elisabetta Ranucci, and Paolo Ferruti, and David Lembo
April 2022, Pharmaceuticals (Basel, Switzerland),
Roberta Cavalli, and Manuela Donalisio, and Agnese Bisazza, and Andrea Civra, and Elisabetta Ranucci, and Paolo Ferruti, and David Lembo
May 2022, Biomaterials advances,
Roberta Cavalli, and Manuela Donalisio, and Agnese Bisazza, and Andrea Civra, and Elisabetta Ranucci, and Paolo Ferruti, and David Lembo
January 2019, Pakistan journal of biological sciences : PJBS,
Roberta Cavalli, and Manuela Donalisio, and Agnese Bisazza, and Andrea Civra, and Elisabetta Ranucci, and Paolo Ferruti, and David Lembo
February 1987, Revue de l'infirmiere,
Roberta Cavalli, and Manuela Donalisio, and Agnese Bisazza, and Andrea Civra, and Elisabetta Ranucci, and Paolo Ferruti, and David Lembo
August 2014, Nanomedicine (London, England),
Roberta Cavalli, and Manuela Donalisio, and Agnese Bisazza, and Andrea Civra, and Elisabetta Ranucci, and Paolo Ferruti, and David Lembo
March 2017, Journal of materials science. Materials in medicine,
Roberta Cavalli, and Manuela Donalisio, and Agnese Bisazza, and Andrea Civra, and Elisabetta Ranucci, and Paolo Ferruti, and David Lembo
April 2019, Colloids and surfaces. B, Biointerfaces,
Roberta Cavalli, and Manuela Donalisio, and Agnese Bisazza, and Andrea Civra, and Elisabetta Ranucci, and Paolo Ferruti, and David Lembo
March 2012, Journal of food science,
Roberta Cavalli, and Manuela Donalisio, and Agnese Bisazza, and Andrea Civra, and Elisabetta Ranucci, and Paolo Ferruti, and David Lembo
October 2011, Drug delivery and translational research,
Copied contents to your clipboard!